Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-07 @ 5:19 AM
Study NCT ID:
NCT03213002
Status:
RECRUITING
Last Update Posted:
2025-04-09
First Post:
2017-07-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Sponsor:
Northwell Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-06
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-05
Last Update Post Date:
2025-04-09
Last Update Post Date Type:
ACTUAL